Rozita Hassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rozita Hassan has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Maen Zreaqat
Universiti Sains Malaysia
4 shared publications Maen Zreaqat
3 shared publications- Muhammad Umar Aslam Khan
Department of Mechanical and Industrial Engineering, Qatar University
3 shared publications - Abdul Rani Samsudin
College of Dental Medicine, University of Sharjah, United Arab Emirates
2 shared publications Abdulfatah Hanoun
Department of Orthodontics, School of Dental Sciences, Universiti Sains Malaysia, Malaysia
2 shared publications- Ahmad Hashridz Bin Ruslan
Orthodontic Unit, School of Dental Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in International Dental Journal
- Vol. 77 (1)
Exploratory Buccal Cytological Changes After Panoramic Radiography
- 4 November 2026
- Published by Elsevier in International Dental Journal
- Vol. 77 (1)
Open AccessExploratory Buccal Cytological Changes After Panoramic Radiography
- Open Access
- 16 October 2026
- Published by MDPI AG in Preprints.org
A Comparative Study Between Arachidonic Acid Treatment and Photobiomodulation Therapy on Bone Remodeling In-Vitro
Background: This study aimed to evaluate the effects of arachidonic acid (AA) and photobiomodulation therapy (PBMT), individually and in combination, on osteoclast and osteoblast activity in-vitro. Methods: Cells were treated with 40 µM AA, 14s of PBMT, or their combination. Untreated cells served as controls. Osteoclast differentiation was assessed using TRAP staining, while migration was evaluated using a transwell assay. Real time PCR assessed osteoclast activity genes such as NFATc1, TRAP, Cat-k, TGF-β, and MMP-9. Osteoblast function was assessed by ALP activity and mRNA expression of RUNX2, ALP, and OCN. The RANKL/OPG ratio was measured using ELISA. Results: PBMT and combined AA+PBMT treatment significantly enhanced cell migration. AA treatment upregulated osteoclastogenic markers and downregulated osteoblast-associated markers and ALP activity. In contrast, PBMT upregulated both osteoclastogenic and osteoblastogenic markers, along with increased ALP activity. The combined AA+PBMT treatment demonstrated enhanced osteoclastogenic activity, but reduced osteoblast-associated markers compared to controls. Additionally, AA and AA+PBMT increased the RANKL/OPG ratio, whereas PBMT decreased their ratio. Conclusions: AA and AA+PBMT treatment potentially favored osteoclastogenesis while PBMT exerted a dual modulatory effect on both osteoclast and osteoblast functions. The findings suggest the applicability of AA and PBMT as adjunctive interventions for bone remodeling.
- 16 October 2026
- Published by MDPI AG in Preprints.org
Open AccessA Comparative Study Between Arachidonic Acid Treatment and Photobiomodulation Therapy on Bone Remodeling In-Vitro
Background: This study aimed to evaluate the effects of arachidonic acid (AA) and photobiomodulation therapy (PBMT), individually and in combination, on osteoclast and osteoblast activity in-vitro. Methods: Cells were treated with 40 µM AA, 14s of PBMT, or their combination. Untreated cells served as controls. Osteoclast differentiation was assessed using TRAP staining, while migration was evaluated using a transwell assay. Real time PCR assessed osteoclast activity genes such as NFATc1, TRAP, Cat-k, TGF-β, and MMP-9. Osteoblast function was assessed by ALP activity and mRNA expression of RUNX2, ALP, and OCN. The RANKL/OPG ratio was measured using ELISA. Results: PBMT and combined AA+PBMT treatment significantly enhanced cell migration. AA treatment upregulated osteoclastogenic markers and downregulated osteoblast-associated markers and ALP activity. In contrast, PBMT upregulated both osteoclastogenic and osteoblastogenic markers, along with increased ALP activity. The combined AA+PBMT treatment demonstrated enhanced osteoclastogenic activity, but reduced osteoblast-associated markers compared to controls. Additionally, AA and AA+PBMT increased the RANKL/OPG ratio, whereas PBMT decreased their ratio. Conclusions: AA and AA+PBMT treatment potentially favored osteoclastogenesis while PBMT exerted a dual modulatory effect on both osteoclast and osteoblast functions. The findings suggest the applicability of AA and PBMT as adjunctive interventions for bone remodeling.
- 10 October 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Effects of Rapid Maxillary Expansion on Facial Soft Tissues in Children With Unilateral Cleft Lip and Palate Using 3-Dimensional Stereophotogrammetry
Objective: To determine the effects of rapid maxillary expansion (RME) on facial soft-tissue dimensions in children with unilateral cleft lip and palate (UCLP) using 3-dimensional stereophotogrammetry. Design: A prospective case series longitudinal study. Setting: Orthodontic Department, School of Dental Sciences. Participants: Thirty-four children with UCLP aged 8 to 10 years presenting with maxillary transverse constriction and requiring RME therapy. Intervention: RME followed by a 6-month retention phase. Main outcome: Changes in facial soft-tissue dimensions after RME using 3-dimensional digital stereophotogrammetry (3dMDface™). Results: At the level of the eyes, changes in the soft-tissue canthal parameters were not statistically significant ( P > .05). At the nasal level, the alar base width and alar base root width increased by 3.22 mm ( P = .033) and 3.03 mm ( P = .028), respectively. No significant differences were observed in the magnitude of change between the cleft and noncleft sides ( P > .05). Intercanine and intermolar widths increased by 5.01 mm and 5.17 mm, respectively (both P < .001). No significant correlations were observed between the magnitude of intercanine or intermolar expansion and changes in alar base width or alar base root width ( P > .05). The remaining soft-tissue variables showed no significant changes ( P > .05). Conclusion: Treatment with RME was associated with significant changes in the nasolabial soft tissues in children with UCLP while having minimal effects on other facial soft-tissue structures. Therapeutic long-term effects remain uncertain, and their potential impact on facial aesthetics should be considered before initiating treatment.
- 10 October 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Effects of Rapid Maxillary Expansion on Facial Soft Tissues in Children With Unilateral Cleft Lip and Palate Using 3-Dimensional Stereophotogrammetry
Objective: To determine the effects of rapid maxillary expansion (RME) on facial soft-tissue dimensions in children with unilateral cleft lip and palate (UCLP) using 3-dimensional stereophotogrammetry. Design: A prospective case series longitudinal study. Setting: Orthodontic Department, School of Dental Sciences. Participants: Thirty-four children with UCLP aged 8 to 10 years presenting with maxillary transverse constriction and requiring RME therapy. Intervention: RME followed by a 6-month retention phase. Main outcome: Changes in facial soft-tissue dimensions after RME using 3-dimensional digital stereophotogrammetry (3dMDface™). Results: At the level of the eyes, changes in the soft-tissue canthal parameters were not statistically significant ( P > .05). At the nasal level, the alar base width and alar base root width increased by 3.22 mm ( P = .033) and 3.03 mm ( P = .028), respectively. No significant differences were observed in the magnitude of change between the cleft and noncleft sides ( P > .05). Intercanine and intermolar widths increased by 5.01 mm and 5.17 mm, respectively (both P < .001). No significant correlations were observed between the magnitude of intercanine or intermolar expansion and changes in alar base width or alar base root width ( P > .05). The remaining soft-tissue variables showed no significant changes ( P > .05). Conclusion: Treatment with RME was associated with significant changes in the nasolabial soft tissues in children with UCLP while having minimal effects on other facial soft-tissue structures. Therapeutic long-term effects remain uncertain, and their potential impact on facial aesthetics should be considered before initiating treatment.
- Open Access
- 3 August 2026
- Published by Springer Nature in BMC Oral Health
Vitamin D deficiency among adults screened for orthodontic treatment in Saudi Arabia: prevalence and implications for trial recruitment
- 3 August 2026
- Published by Springer Nature in BMC Oral Health
Open AccessVitamin D deficiency among adults screened for orthodontic treatment in Saudi Arabia: prevalence and implications for trial recruitment
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Umbrella review of photobiomodulation/low-level laser therapy and vitamin D in orthodontics: effects on tooth movement, pain, root resorption, and bone biomarkers
To synthesize evidence from systematic reviews and meta-analyses on low-level laser therapy/Photobiomodulation (LLLT/PBM) and vitamin D as non-invasive adjuncts for accelerating orthodontic tooth movement (OTM) and mitigating associated side effects. PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library databases were searched from inception to November 18, 2025. SRMAs primarily comprising human RCTs evaluating LLLT/PBM or vitamin D in orthodontics were included; in some mixed-design reviews, clearly separable human orthodontic data from a small number of CCTs were retained narratively. (one pre-registered exception with 4 RCTs for vitamin D to ensure completeness). Randomized controlled trials were prioritized; some retained reviews also included a small number of controlled clinical trials when relevant human orthodontic data were clearly separable. Quality was assessed using AMSTAR-2, ROBIS, and GRADE. Narrative synthesis was performed because of high heterogeneity. Twenty systematic reviews and meta-analyses covering a large number of human orthodontic trials were included. Low-certainty evidence suggests that LLLT/PBM may be associated with accelerated OTM, slight reductions in orthodontically induced inflammatory root resorption (OIIRR), and short-term pain relief. Vitamin D showed inconsistent findings across outcomes with no reliable overall clinical benefit. Current evidence is insufficient to recommend the routine clinical use of LLLT/PBM or vitamin D in orthodontics. PROSPERO CRD42024591253.
- 16 July 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessUmbrella review of photobiomodulation/low-level laser therapy and vitamin D in orthodontics: effects on tooth movement, pain, root resorption, and bone biomarkers
To synthesize evidence from systematic reviews and meta-analyses on low-level laser therapy/Photobiomodulation (LLLT/PBM) and vitamin D as non-invasive adjuncts for accelerating orthodontic tooth movement (OTM) and mitigating associated side effects. PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library databases were searched from inception to November 18, 2025. SRMAs primarily comprising human RCTs evaluating LLLT/PBM or vitamin D in orthodontics were included; in some mixed-design reviews, clearly separable human orthodontic data from a small number of CCTs were retained narratively. (one pre-registered exception with 4 RCTs for vitamin D to ensure completeness). Randomized controlled trials were prioritized; some retained reviews also included a small number of controlled clinical trials when relevant human orthodontic data were clearly separable. Quality was assessed using AMSTAR-2, ROBIS, and GRADE. Narrative synthesis was performed because of high heterogeneity. Twenty systematic reviews and meta-analyses covering a large number of human orthodontic trials were included. Low-certainty evidence suggests that LLLT/PBM may be associated with accelerated OTM, slight reductions in orthodontically induced inflammatory root resorption (OIIRR), and short-term pain relief. Vitamin D showed inconsistent findings across outcomes with no reliable overall clinical benefit. Current evidence is insufficient to recommend the routine clinical use of LLLT/PBM or vitamin D in orthodontics. PROSPERO CRD42024591253.
- 9 October 2025
- Published by Oxford University Press (OUP) in Dentomaxillofacial Radiology
- Vol. 55 (3) , 235-251
Micronucleus formation in oral mucosal cells following dental X-ray exposure: a systematic review and meta-analysis
Background: Radiographic imaging is essential in dental diagnostics, yet concerns persist regarding its genotoxic impact. While digital advancements have reduced radiation doses, the effects of X-ray exposure on oral mucosal cells remain debated. This study systematically reviews and quantitatively analyses the effects of X-ray exposure on micronucleus (MN) formation in oral epithelial cells, examining potential age-related variations. Methods: A thorough literature review was performed across PubMed, Web of Science, EBSCO, and Scopus (updated to November 2024), adhering to PRISMA criteria. Eligible studies examined cytogenetic changes in oral epithelial cells after X-ray exposure in healthy individuals. Data extraction covered study design, imaging modality, radiation dose, MN frequency, and statistical methods. Risk of bias was assessed using a modified Effective Public Health Practice Project tool. A random-effects model synthesized MN frequency changes, and Fisher’s Z-transformation analysed age correlations. Results: Eighteen studies met the inclusion criteria, with 16 centred on panoramic imaging and 2 examining a combination of cone-beam computed tomography and lateral cephalometric X-rays. Meta-analysis confirmed a significant increase in MN frequency post-exposure (standardized mean difference = 0.30, 95% CI: 0.07-0.52, P = .01), indicating genotoxic effects. However, age showed a weak correlation with MN formation (r = 0.149, 95% CI: −0.009 to 0.3, P = .065). Conclusions: X-ray exposure induces measurable genotoxic damage in oral epithelial cells, though age-related effects remain inconclusive. Adhering to the ALARA principle is crucial to minimizing unnecessary radiation. Future studies should employ larger cohorts and refined biomarkers to enhance risk assessment.
- 9 October 2025
- Published by Oxford University Press (OUP) in Dentomaxillofacial Radiology
- Vol. 55 (3) , 235-251
Micronucleus formation in oral mucosal cells following dental X-ray exposure: a systematic review and meta-analysis
Background: Radiographic imaging is essential in dental diagnostics, yet concerns persist regarding its genotoxic impact. While digital advancements have reduced radiation doses, the effects of X-ray exposure on oral mucosal cells remain debated. This study systematically reviews and quantitatively analyses the effects of X-ray exposure on micronucleus (MN) formation in oral epithelial cells, examining potential age-related variations. Methods: A thorough literature review was performed across PubMed, Web of Science, EBSCO, and Scopus (updated to November 2024), adhering to PRISMA criteria. Eligible studies examined cytogenetic changes in oral epithelial cells after X-ray exposure in healthy individuals. Data extraction covered study design, imaging modality, radiation dose, MN frequency, and statistical methods. Risk of bias was assessed using a modified Effective Public Health Practice Project tool. A random-effects model synthesized MN frequency changes, and Fisher’s Z-transformation analysed age correlations. Results: Eighteen studies met the inclusion criteria, with 16 centred on panoramic imaging and 2 examining a combination of cone-beam computed tomography and lateral cephalometric X-rays. Meta-analysis confirmed a significant increase in MN frequency post-exposure (standardized mean difference = 0.30, 95% CI: 0.07-0.52, P = .01), indicating genotoxic effects. However, age showed a weak correlation with MN formation (r = 0.149, 95% CI: −0.009 to 0.3, P = .065). Conclusions: X-ray exposure induces measurable genotoxic damage in oral epithelial cells, though age-related effects remain inconclusive. Adhering to the ALARA principle is crucial to minimizing unnecessary radiation. Future studies should employ larger cohorts and refined biomarkers to enhance risk assessment.
- 20 August 2025
- Published by Jaypee Brothers Medical Publishing in The Journal of Contemporary Dental Practice
- Vol. 26 (6) , 598-607
Evaluation of Patient-reported Outcome Measures during the Correction of Skeletal Class III Malocclusion with Maxillary Constriction in Early Adolescence
This randomized controlled trial (RCT) aimed to evaluate the patient-reported outcome measures (PROMs) when treated with the bone-anchored intermaxillary traction (BAIMT) associated with rapid maxillary expansion (RME) and the removable mandibular retractor (RMR) associated with slow maxillary expansion (SME). This was a single-center 2-arm RCT accomplished between September 2021 and September 2023 involving patients aged between 12 and 15 years and diagnosed with skeletal class III (SCIII) and maxillary constriction. The patients were randomly divided into the BAIMT/RME group and the RMR/SME group. The levels of pain, discomfort, and functional impairment were evaluated by a standardized questionnaire at five assessment times: (T1) after a day, (T2) after a week (T3) after 4 weeks, (T4) after 3 months, and (T5) after 6 months following treatment onset. Twenty-four patients (13 males and 11 females) were included without any dropouts. No statistically significant differences were found between both groups in any of the assessment time points regarding the studied variables (p > 0.01). High levels of patients' confidence were reported in both groups without any significant difference (p > 0.01). Treatment of class III malocclusion in growing patients by both appliances did not negatively affect PROMs. Moreover, the application of both appliances was associated with a gradual improvement in the levels of pain and functional impairments until they were almost nonexistent after 6 months. Application of both the BAIMT/RME and RMR/SME in adolescents with SCIII patients is associated with comparable and acceptable levels of pain, discomfort, functional impairment, and shame. This study was registered in ClinicalTrials.gov (ID: NCT06877780). How to cite this article: Zakaria AS, Hassan R, Baharin F, et al. Evaluation of Patient-reported Outcome Measures during the Correction of Skeletal Class III Malocclusion with Maxillary Constriction in Early Adolescence. J Contemp Dent Pract 2025;26(6):598-607.
- 20 August 2025
- Published by Jaypee Brothers Medical Publishing in The Journal of Contemporary Dental Practice
- Vol. 26 (6) , 598-607
Evaluation of Patient-reported Outcome Measures during the Correction of Skeletal Class III Malocclusion with Maxillary Constriction in Early Adolescence
This randomized controlled trial (RCT) aimed to evaluate the patient-reported outcome measures (PROMs) when treated with the bone-anchored intermaxillary traction (BAIMT) associated with rapid maxillary expansion (RME) and the removable mandibular retractor (RMR) associated with slow maxillary expansion (SME). This was a single-center 2-arm RCT accomplished between September 2021 and September 2023 involving patients aged between 12 and 15 years and diagnosed with skeletal class III (SCIII) and maxillary constriction. The patients were randomly divided into the BAIMT/RME group and the RMR/SME group. The levels of pain, discomfort, and functional impairment were evaluated by a standardized questionnaire at five assessment times: (T1) after a day, (T2) after a week (T3) after 4 weeks, (T4) after 3 months, and (T5) after 6 months following treatment onset. Twenty-four patients (13 males and 11 females) were included without any dropouts. No statistically significant differences were found between both groups in any of the assessment time points regarding the studied variables (p > 0.01). High levels of patients' confidence were reported in both groups without any significant difference (p > 0.01). Treatment of class III malocclusion in growing patients by both appliances did not negatively affect PROMs. Moreover, the application of both appliances was associated with a gradual improvement in the levels of pain and functional impairments until they were almost nonexistent after 6 months. Application of both the BAIMT/RME and RMR/SME in adolescents with SCIII patients is associated with comparable and acceptable levels of pain, discomfort, functional impairment, and shame. This study was registered in ClinicalTrials.gov (ID: NCT06877780). How to cite this article: Zakaria AS, Hassan R, Baharin F, et al. Evaluation of Patient-reported Outcome Measures during the Correction of Skeletal Class III Malocclusion with Maxillary Constriction in Early Adolescence. J Contemp Dent Pract 2025;26(6):598-607.
- Open Access
- 12 June 2025
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 15 (4) , 864-868
Effects of twin-block appliance on quality of life in OSA children with class 2 malocclusion and mandibular retrognathia
- 12 June 2025
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 15 (4) , 864-868
Open AccessEffects of twin-block appliance on quality of life in OSA children with class 2 malocclusion and mandibular retrognathia
- Open Access
- 1 May 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (3) , 801-815
Hydroxyapatite, polyetheretherketone, and stainless steel as orthodontic mini-implant biomaterial candidates: A bioinformatic approach
Context: Orthodontic mini-implants (OMIs) are temporary devices affixed to bones that aim to improve absolute anchoring during orthodontic treatment for malocclusion. Stainless steel (SS), polyetheretherketone (PEEK), and hydroxyapatite (HA) are substitute materials that might work well together. To determine how SS, PEEK, and HA interact with bone molecular target proteins linked to resistant types of OMI, a molecular docking investigation and an in silico analysis were carried out. Aims: To analyze the binding activity of SS, PEEK, and HA to bone molecular target proteins in silico as potential OMI biomaterial candidates. Methods: Osteocalcin, osteonectin, bone morphogenic protein (BMP)4, BMP2, BMP7, alkaline phosphatase (ALP), runt-related transcription factor-2 (RUNX2), insulin growth factor-1 (IGF1), osterix, tartrate-resistant acid phosphatase (TRAPase), and collagen type 1a1 (COL1A1) biomolecular interaction patterns were used in molecular docking to identify ligand activity on target proteins using negative binding affinity. Network prediction was used to investigate the activation and inhibition of the ligand complex on target proteins. Results: Bone molecular target proteins, such as IGF1 and osteopontin, bind to SS, PEEK, and HA ligands with a strong negative binding affinity, causing ligand activation or inhibition. Out of all the variables, the combination of SS, PEEK, and HA had the largest negative value. Conclusions: As shown in silico, SS, PEEK, and HA ligands have a high binding affinity for resistance-form-related bone target proteins, such as IGF1 and osteopontin, making them potentially useful as OMI biomaterials.
- 1 May 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (3) , 801-815
Open AccessHydroxyapatite, polyetheretherketone, and stainless steel as orthodontic mini-implant biomaterial candidates: A bioinformatic approach
Context: Orthodontic mini-implants (OMIs) are temporary devices affixed to bones that aim to improve absolute anchoring during orthodontic treatment for malocclusion. Stainless steel (SS), polyetheretherketone (PEEK), and hydroxyapatite (HA) are substitute materials that might work well together. To determine how SS, PEEK, and HA interact with bone molecular target proteins linked to resistant types of OMI, a molecular docking investigation and an in silico analysis were carried out. Aims: To analyze the binding activity of SS, PEEK, and HA to bone molecular target proteins in silico as potential OMI biomaterial candidates. Methods: Osteocalcin, osteonectin, bone morphogenic protein (BMP)4, BMP2, BMP7, alkaline phosphatase (ALP), runt-related transcription factor-2 (RUNX2), insulin growth factor-1 (IGF1), osterix, tartrate-resistant acid phosphatase (TRAPase), and collagen type 1a1 (COL1A1) biomolecular interaction patterns were used in molecular docking to identify ligand activity on target proteins using negative binding affinity. Network prediction was used to investigate the activation and inhibition of the ligand complex on target proteins. Results: Bone molecular target proteins, such as IGF1 and osteopontin, bind to SS, PEEK, and HA ligands with a strong negative binding affinity, causing ligand activation or inhibition. Out of all the variables, the combination of SS, PEEK, and HA had the largest negative value. Conclusions: As shown in silico, SS, PEEK, and HA ligands have a high binding affinity for resistance-form-related bone target proteins, such as IGF1 and osteopontin, making them potentially useful as OMI biomaterials.
- Open Access
- 24 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e61025
Efficacy of Oxy-Ionic Solutions With Varying pH Levels Against Streptococcus mutans In Vitro
Background Chlorhexidine (CHX) is a widely used antimicrobial agent known for its ability to inhibit cariogenic bacteria, reduce plaque formation, neutralize acidity, and promote remineralization. However, the effectiveness of oxy-ionic solutions at different pH levels as an alternative antimicrobial treatment requires further exploration. This study aims to compare the antimicrobial effects of oxy-ionic solutions at various pH levels with those of CHX and fluoride. Methodology This study employed disc diffusion tests to measure the inhibition zone diameters of each solution and broth dilution assays to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Results The oxy-ionic solutions exhibited varying degrees of antimicrobial effectiveness depending on their pH levels. The solution at pH 5 demonstrated the best antimicrobial performance among the oxy-ionic solutions, with inhibition zones comparable to those of CHX. The MIC and MBC values indicated that oxy-ionic solutions in mildly acidic environments generally resulted in better antimicrobial activity. Conclusions The study concludes that while CHX remains highly effective against cariogenic bacteria, oxy-ionic solutions, particularly at pH 5, offer a promising alternative. The antimicrobial efficacy of oxy-ionic solutions is influenced by their pH levels. Further research is recommended to explore the long-term effects and clinical applications of oxy-ionic solutions in maintaining oral health and preventing disease.
- 24 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e61025
Open AccessEfficacy of Oxy-Ionic Solutions With Varying pH Levels Against Streptococcus mutans In Vitro
Background Chlorhexidine (CHX) is a widely used antimicrobial agent known for its ability to inhibit cariogenic bacteria, reduce plaque formation, neutralize acidity, and promote remineralization. However, the effectiveness of oxy-ionic solutions at different pH levels as an alternative antimicrobial treatment requires further exploration. This study aims to compare the antimicrobial effects of oxy-ionic solutions at various pH levels with those of CHX and fluoride. Methodology This study employed disc diffusion tests to measure the inhibition zone diameters of each solution and broth dilution assays to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Results The oxy-ionic solutions exhibited varying degrees of antimicrobial effectiveness depending on their pH levels. The solution at pH 5 demonstrated the best antimicrobial performance among the oxy-ionic solutions, with inhibition zones comparable to those of CHX. The MIC and MBC values indicated that oxy-ionic solutions in mildly acidic environments generally resulted in better antimicrobial activity. Conclusions The study concludes that while CHX remains highly effective against cariogenic bacteria, oxy-ionic solutions, particularly at pH 5, offer a promising alternative. The antimicrobial efficacy of oxy-ionic solutions is influenced by their pH levels. Further research is recommended to explore the long-term effects and clinical applications of oxy-ionic solutions in maintaining oral health and preventing disease.